Coldstream Capital Management Inc Verrica Pharmaceuticals Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 711 shares of VRCA stock, worth $5,652. This represents 0.0% of its overall portfolio holdings.
Number of Shares
711Holding current value
$5,652% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VRCA
# of Institutions
73Shares Held
20.3MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY8.57MShares$68.1 Million1.04% of portfolio
-
Boothbay Fund Management, LLC New York, NY2.81MShares$22.3 Million0.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.36MShares$18.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.13MShares$8.98 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.02MShares$8.1 Million0.0% of portfolio
About Verrica Pharmaceuticals Inc.
- Ticker VRCA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,094,100
- Market Cap $327M
- Description
- Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...